About: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (en) A Study of Atezolizumab in Combination With Carboplatin Plus (nl)
skos:prefLabel	A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (en) A Study of Atezolizumab in Combination With Carboplatin Plus (nl)
name	A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (en) A Study of Atezolizumab in Combination With Carboplatin Plus (nl)
title	wds:Q65348386-370C13AA-8BA2-4621-97E8-2B8B11F62E31
title	A Phase III Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) in Combination With Carboplatin+Nab-Paclitaxel for Chemotherapy-Naive Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (en)
end time	wds:Q65348386-16A703CB-D16A-4AC6-B351-004E5BB012A0
end time	2018-03-15 00:00:00Z (xsd:dateTime)
instance of	wds:Q65348386-35867AF1-C807-4997-8778-258B0E9CCF7A
instance of	clinical trial
start time	wds:Q65348386-F6974424-19A9-434D-B863-CDBEECD5B1DA
start time	2015-04-16 00:00:00Z (xsd:dateTime)
country	wds:Q65348386-A6A1541D-C870-41AB-9F54-39336CF6D050 wds:Q65348386-B1DF9305-3CB0-4CDD-AE04-F3E444184960 wds:Q65348386-C6A7EDD0-8975-42E5-B3E0-95541D86015F wds:Q65348386-CE55DA3C-8701-49E9-A508-9DD264C66F0D wds:Q65348386-D4DF704C-E7E6-4248-9092-D6D1BA5B0F00 wds:Q65348386-D973C857-05F2-474E-9EE5-7AD5869447FB wds:Q65348386-DBA1C995-0993-40B6-8067-76275404B1D1 wds:Q65348386-DDA21024-ECF4-4083-9A75-924417BE1AD5
country	Israel Italy Malawi Spain France Belgica metro station United States of America Germany
research site	wds:Q65348386-04BEC1E3-6E1E-4104-A60A-DB135DE67365 wds:Q65348386-0DF9AD3A-CF27-4919-8483-00916181B100 wds:Q65348386-1083FE4A-4F76-4682-880B-4CF7DE2BC33A wds:Q65348386-2ED747C8-9940-48F8-AAD3-B235FF94FAEF wds:Q65348386-3AAD5D60-030D-4904-9AD3-C13FFD2F707D wds:Q65348386-5185B06E-6243-4777-9DA7-E0D5D3464D01 wds:Q65348386-5A3DD38A-1263-425B-B1BE-63E790C5A6F1 wds:Q65348386-5C4A2310-67BF-45B7-BDB1-575E4D2FE60C wds:Q65348386-60B538AE-0B15-4B5E-9977-9E52625E950A wds:Q65348386-718FAD8C-0662-4D90-9679-19C85B6F1E86 wds:Q65348386-7CB8B40A-6DAB-4289-9A92-1650B9E76361 wds:Q65348386-82294176-7F45-46E5-89D3-19923917147A wds:Q65348386-887AA89F-5AC5-4288-A0F2-6C71D06919AC wds:Q65348386-9061E427-622A-4800-A322-2B81F3DB1887 wds:Q65348386-92EF18BA-DF64-4579-9D21-5861755958CF wds:Q65348386-B475184D-5473-4582-B46F-63C9B93BD987 wds:Q65348386-B8DF197A-2D47-4963-9BFF-DEAAD963F0DC wds:Q65348386-BE0E81DA-189B-426A-B317-3790CD80FC2C wds:Q65348386-D4107824-F16F-490A-822D-56A41759FB18 wds:Q65348386-DBEE9BBE-8C31-4008-9D88-0CD060937070 wds:Q65348386-E78B5F68-70E0-4379-A5D5-A7A8EFA8EDB0 wds:Q65348386-F8305D30-6826-46D1-B7AA-16ADB8CCEE8A
research site	Kaplan Medical Center Tel Aviv University University of Texas at Houston Police Department Hannover Medical School Rabin Medical Center Galilee Medical Center Mayo Clinic Hospital Universitario de Canarias The Christ Hospital Englewood Hospital and Medical Center Lancaster General Hospital Rhode Island Hospital Saint Barnabas Medical Center Hospital General Universitari de València Catholic University of Applied Social Sciences Consorcio Hospitalario Provincial de Castellón Hospital de Son Llàtzer Jaen University Hospital Pontchaillou hospital Krankenhaus Nordwest Hospital Universitario Virgen de las Nieves Florida Hospital Cancer Institute
short name	wds:Q65348386-A0C82CF7-A16D-4845-B607-0FA61AE16463
short name	IMpower130 (en)
research intervention	wds:Q65348386-5B8BCFB9-AFA2-49D4-B849-77514C899DDC wds:Q65348386-78CA9A05-A07A-4B97-A2EA-ECEF19353AF2 wds:Q65348386-BC03D569-C1D5-426A-89E3-AF2DD941193A
research intervention	wd:Q423762 carboplatin pemetrexed
minimum age	wds:Q65348386-55BE374C-EE66-4E14-B586-B8836E37C356
minimum age	18 (xsd:decimal)
located in the adm...erritorial entity	wds:Q65348386-4ECF275F-3E38-490D-9FB8-C9E122BF0FEA
sponsor	wds:Q65348386-2AE26718-0528-457A-9177-33E17B837E3C
located in the adm...erritorial entity	Hong Kong Pro Cycling
sponsor	Chemische Werke Grenzach
number of participants	wds:Q65348386-F3BB7FE2-4946-4AD9-AE25-C4D9ADF4FED4
number of participants	723 (xsd:decimal)
study type	wds:Q65348386-F06BD311-2C9E-4C9D-9880-0D48CBBB6AE9
study type	interventional study
ClinicalTrials.gov ID	wds:Q65348386-522D27C5-3814-4C51-8259-0BC7D7471854
ClinicalTrials.gov ID	NCT02367781
clinical trial phase	wds:Q65348386-90A6204B-126A-4A8F-81EF-2C2173D87CB7

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software